Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Option Of Concluding Them Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Dexketoprofen (m01ae17)drug 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Option Of Concluding Them Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Drug 2026-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Rotigotine (atc Code According To Who 2026-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tiotropium Bromide (atc Code According To Who 2026-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Infliximab For Subcutaneous Injection (atc Code According To Who 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Option Of Concluding Them Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Conclusion Not Exclusive Of Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Brinzolamide/timolol (official Atcc Code 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Option Of Concluding Them Within The Framework Of The So-called Open House Procedure. 2026-12-31
Whats app